Back to News

China's AI drug discovery companies land deals with Big Pharma

Hacker News - AI
Aug 6, 2025 18:14
speckx
1 views
hackernewsaidiscussion

Summary

Chinese AI drug discovery startups are increasingly partnering with major pharmaceutical companies, signaling global recognition of their technological capabilities. These collaborations highlight China's growing influence in AI-driven drug development and may accelerate innovation and competition in the pharmaceutical industry.

Article URL: https://restofworld.org/2025/ai-drug-discovery-startups-big-pharma-china/ Comments URL: https://news.ycombinator.com/item?id=44815613 Points: 2 # Comments: 0
Read Full ArticleMore News

Related Articles

I made an AI clone of my dead son – and let a journalist interview him

Hacker News - AIAug 9

A grieving father used AI technology to create a digital clone of his deceased son, allowing a journalist to interact with the virtual version. This experiment highlights both the emotional potential and ethical challenges of using AI for personal loss, raising important questions about memory, consent, and the boundaries of digital resurrection.

The Future of Product Management Is AI-Native

Hacker News - AIAug 9

The article argues that product management is evolving to become "AI-native," meaning that AI will be deeply integrated into every stage of product development, from ideation to deployment. This shift requires product managers to develop new skills in data, machine learning, and ethical considerations, fundamentally changing how products are conceived and managed in the AI era.

Show HN: Create art your way with Flux Lora AI

Hacker News - AIAug 9

Flux Lora AI is a new platform that enables users to create art through customizable AI models, allowing for greater creative control and personalization. This tool highlights the growing trend of democratizing AI-powered art generation, making advanced creative technologies more accessible to a wider audience. Its launch reflects ongoing innovation in user-friendly AI applications within the creative sector.